Related Articles
miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin
Upregulation of microRNA‑375 increases the cisplatin‑sensitivity of human gastric cancer cells by regulating ERBB2
Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21
MicroRNA‑200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER‑ERCC3/4 pathway
miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD